A phase II study of bevacizumab, docetaxel and oxaliplatin in gastric and gastroesophageal junction (GEJ) cancer

被引：1
|
作者：
El-Rayes, B. F. [1 ]
Hammad, N. [1 ]
Philip, P. A. [1 ]
Shields, A. F. [1 ]
Heilbrun, L. K. [1 ]
机构：
[1] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15608
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15608
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II study of bevacizumab, docetaxel, and oxaliplatin in gastric and GEJ cancer
    El-Rayes, B. F.
    Patel, B.
    Zalupski, M.
    Hammad, N.
    Shields, A.
    Heilbrun, L.
    Venkatramanamoorthy, R.
    Philip, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Epirubicin, oxaliplatin, and docetaxel (EOD) combination in metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma: A phase II study
    Di Lauro, L.
    Giacinti, L.
    Arena, M. G.
    Fattoruso, S. I.
    Foggi, P.
    Lopez, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers
    El-Rayes, B. F.
    Zalupski, M.
    Bekai-Saab, T.
    Heilbrun, L. K.
    Hammad, N.
    Patel, B.
    Urba, S.
    Shields, A. F.
    Vaishampayan, U.
    Dawson, S.
    Almhanna, K.
    Smith, D.
    Philip, P. A.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (10) : 1999 - 2004
  • [4] Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction
    Richards, D.
    McCollum, D.
    Wilfong, L.
    Sborov, M.
    Boehm, K. A.
    Zhan, F.
    Asmar, L.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (01) : 104 - 108
  • [5] Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma
    Di Lauro, Luigi
    Giacinti, Laura
    Arena, Maria Grazia
    Sergi, Domenico
    Fattoruso, Silvia Ileana
    Giannarelli, Diana
    Lopez, Massimo
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009, 28
  • [6] Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma
    Luigi Di Lauro
    Laura Giacinti
    Maria Grazia Arena
    Domenico Sergi
    Silvia Ileana Fattoruso
    Diana Giannarelli
    Massimo Lopez
    [J]. Journal of Experimental & Clinical Cancer Research, 28
  • [7] Oxaliplatin in perioperative chemotherapy for gastric and gastroesophageal junction (GEJ) adenocarcinoma
    Fritsch, Ralph
    Hoeppner, Jens
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (04) : 285 - 291
  • [8] Docetaxel, oxaliplatin, and capecitabine (DOX) combination chemotherapy for metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma.
    Di Lauro, Luigi
    Sergi, Domenico
    Belli, Franca
    Fattoruso, Silvia Ileana
    Arena, Maria Grazia
    Pizzuti, Laura
    Vici, Patrizia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] A phase II study of capecitabine-oxaliplatin and cetuximab in patients (pts) with advanced/metastatic gastric cancer (G) or gastroesophageal junction (GEJ) adenocarcinoma.
    Iqbal, Syma
    El-Khoueiry, Anthony B.
    Yang, Dongyun
    Paez, David
    Duddalwar, Vinay
    Zhang, Wu
    Agafitei, Raluca Dana
    Lujan, Ramona
    Cole, Sarah
    Ning, Yan
    El-Khoueiry, Rita
    Loupakis, Fotios
    Wakatsuki, Takeru
    Lenz, Heinz-Josef
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] A phase II study: Combination of sorafenib with docetaxel and cisplatin in the treatment of metastatic or advanced unresectable gastric and gastroesophageal junction (GEJ) adenocarcinoma (ECOG 5203)
    Sun, W.
    Powell, M. E.
    O'Dwyer, P.
    Ansari, R. H.
    Benson, A. B., III
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345